abstract |
The present invention is directed to a method of treating cancer, comprising administering a compound that selectively inhibits the activity of one or two isoforms of Akt, a serine / threonine protein kinase. . The invention is specifically directed to methods wherein the compound depends on the presence of the pleckstrin homology domain of Akt for its inhibitory activity. |